Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oncolytic virotherapy trials--letter.
Clin Cancer Res. 2013 Aug 15;19(16):4541-2. doi: 10.1158/1078-0432.CCR-13-1471.
Clin Cancer Res. 2013.
PMID: 23946419
No abstract available.
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
Bramante S, Koski A, Kipar A, Diaconu I, Liikanen I, Hemminki O, Vassilev L, Parviainen S, Cerullo V, Pesonen SK, Oksanen M, Heiskanen R, Rouvinen-Lagerström N, Merisalo-Soikkeli M, Hakonen T, Joensuu T, Kanerva A, Pesonen S, Hemminki A.
Bramante S, et al. Among authors: merisalo soikkeli m.
Int J Cancer. 2014 Aug 1;135(3):720-30. doi: 10.1002/ijc.28696. Epub 2014 Jan 10.
Int J Cancer. 2014.
PMID: 24374597
Free article.
Item in Clipboard
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor.
Tähtinen S, Grönberg-Vähä-Koskela S, Lumen D, Merisalo-Soikkeli M, Siurala M, Airaksinen AJ, Vähä-Koskela M, Hemminki A.
Tähtinen S, et al. Among authors: merisalo soikkeli m.
Cancer Immunol Res. 2015 Aug;3(8):915-25. doi: 10.1158/2326-6066.CIR-14-0220-T. Epub 2015 May 14.
Cancer Immunol Res. 2015.
PMID: 25977260
Item in Clipboard
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.
Liikanen I, Koski A, Merisalo-Soikkeli M, Hemminki O, Oksanen M, Kairemo K, Joensuu T, Kanerva A, Hemminki A.
Liikanen I, et al. Among authors: merisalo soikkeli m.
Oncoimmunology. 2015 Apr 2;4(3):e989771. doi: 10.4161/2162402X.2014.989771. eCollection 2015 Mar.
Oncoimmunology. 2015.
PMID: 25949903
Free PMC article.
Item in Clipboard
Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
Tähtinen S, Kaikkonen S, Merisalo-Soikkeli M, Grönberg-Vähä-Koskela S, Kanerva A, Parviainen S, Vähä-Koskela M, Hemminki A.
Tähtinen S, et al. Among authors: merisalo soikkeli m.
PLoS One. 2015 Jun 24;10(6):e0131242. doi: 10.1371/journal.pone.0131242. eCollection 2015.
PLoS One. 2015.
PMID: 26107883
Free PMC article.
Item in Clipboard
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.
Vähä-Koskela M, Tähtinen S, Grönberg-Vähä-Koskela S, Taipale K, Saha D, Merisalo-Soikkeli M, Ahonen M, Rouvinen-Lagerström N, Hirvinen M, Veckman V, Matikainen S, Zhao F, Pakarinen P, Salo J, Kanerva A, Cerullo V, Hemminki A.
Vähä-Koskela M, et al. Among authors: merisalo soikkeli m.
Mol Ther Oncolytics. 2015 Jan 7;1:14006. doi: 10.1038/mto.2014.6. eCollection 2015.
Mol Ther Oncolytics. 2015.
PMID: 27119097
Free PMC article.
Item in Clipboard
Cite
Cite